IPO Market Unlocking for 'Omics-related Companies, but It's 'Anything but Robust' | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – For most of 2010, the IPO market froze out the life science tools and 'omics market, but by the end of the summer, there were signs that the public markets may be slowly welcoming firms operating in the space, as a handful of public offerings ended a cold snap.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.